期刊文献+

齐拉西酮与利培酮治疗精神分裂症对照研究 被引量:2

Comparative analysis between ziprasidone and risperidone in teratment of schizophrenia
下载PDF
导出
摘要 目的:探讨齐拉西酮与利培酮治疗精神分裂症的疗效和安全性。方法:将60例精神分裂症患者随机分为齐拉西酮组和利培酮组,每组30例。疗程8周,采用阳性与阴性症状量表(PANSS)和治疗中出现的症状量表(TESS)评定疗效和不良反应。结果:齐拉西酮组有效率83.3%,显效率70.0%,利培酮组有效率86.7%,显效率73.3%。结论:齐拉西酮治疗精神分裂症疗效较好与利培酮相当,不良反应少。 Objective:To explore the efficacy and safety of ziprasidone in treatment of schizophrenia. Methods:60 patients with schizophreia were randomly assigned two groups ziprasidone group (n = 30) and respenridone group (n = 30) for 8 week. Positive and negative syndrome scale (PANSS) and treatment side effect scale (TESS)were used to evaluate the efficacy and side effects respectively. Results: The response rate and marked response rate was 83.3% andT0.0% in ziprasidone treatment patients,and which was 86.7% and 73.3% in risperidone randomly patients. Conclusions: Ziprasidone has better treatment efficacy and less adverse effects in schizophrenia.
出处 《中国民康医学》 2008年第17期2002-2002,2004,共2页 Medical Journal of Chinese People’s Health
关键词 齐拉西酮 利培酮 精神分裂症 Ziprasidone Resperidone Schizophrenia
  • 相关文献

参考文献5

二级参考文献7

共引文献517

同被引文献13

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部